libtayo (cemiplimab) 350mg/7ml


Get it to United States within 10 working days with standard delivery.

Fast delivery to United States

Easy Returns & Exchanges

Ask About This Product

Condition : New


From UAE

To United States

in 5-10 days


How Libtayo Works

Libtayo is a medication used in the treatment of certain types of cancer, particularly advanced or metastatic cutaneous squamous cell carcinoma (CSCC) and advanced basal cell carcinoma (BCC). It belongs to a class of drugs known as checkpoint inhibitors. Libtayo works by targeting and blocking a protein called programmed death receptor-1 (PD-1) on certain immune cells, allowing the immune system to recognize and attack cancer cells more effectively. By enhancing the body’s immune response against cancer, Libtayo helps to slow down or stop the growth and spread of cancerous cells.

Side Effects of Libtayo

  • Fatigue
  • Nausea
  • Diarrhea
  • Decreased appetite
  • Rash or itching
  • Fever
  • Cough
  • Joint pain
  • Weight loss
These side effects may vary in severity and may require medical attention depending on individual circumstances.

Indications for Libtayo

  • Advanced or metastatic cutaneous squamous cell carcinoma (CSCC)
  • Advanced basal cell carcinoma (BCC)

Contraindications for Libtayo

  • Hypersensitivity to cemiplimab or any component of the formulation
  • Active autoimmune disease that has required systemic treatment within the past 2 years
  • Severe infections
  • History of solid organ transplantation
— **

Price Comparison of Libtayo in Different Countries

Country Price (per tablet) Reference
Pakistan PKR 50,000 Pakistan
United States USD 2,500 Sanofi US
United Kingdom GBP 1,800 Sanofi UK
Canada CAD 3,000 Sanofi Canada
Australia AUD 3,500 Sanofi Australia

Top 5 Global Brands of Cancer Immunotherapy Medications

  1. Keytruda (Pembrolizumab)
  2. Opdivo (Nivolumab)
  3. Yervoy (Ipilimumab)
  4. Libtayo (Cemiplimab)
  5. Tecentriq (Atezolizumab)
Shopping Cart